Through genomic analysis we found that genomic mutations especially amplification of UPK1A gene was usually observed in various cancers, including uterine carcinosarcoma, ovarian serous cystadenocarcinoma, lung cancer, pancreatic adenocarcinoma. Here, UPK1A is linked to pancreatic adenocarcinoma.